PAB Tri-Axis Balanced Series II-AG

Brassica nigra

Black Mustard

Tier IIPAB Tri-Axis Balanced Series

Target Trait

1.38×

fold-change

Sharp+Astringency+Bitter-Attenuation balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01556

Genomic Edits

GC Content

44.4%

Construct Length

4,698 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPA1 + Polyphenol-astringency axis + TAS2R38 (suppression)

IFI Score

138

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PAB pathway operation
Cross-pathway regulatory circuit for balanced PAB triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, Polyphenol-astringency axis, and TAS2R38 (suppression) pathways simultaneously engineeredBalanced tri-axis expression strategy (PAB) with cross-pathway flux managementT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier II PAB triple-axis construct for advanced multi-modal sensory architecture combining sharp, astringency, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities